Economy
Durable Goods Orders
New orders increased on the faster pace again, excluding defense booking grew even faster 1.05 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.
|
Factory Orders
Factory orders continued to grow, excluding defense, booking grew even faster 1.56 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.
|
Gross Domestic Product
The Gross domestic product, the measurement of the nations output, improved in the fourth-quarter, as private domestic investments and foreign demand for American products pick up.
|
|
![Mobilfunkantennenanlage_Niwre_at_the_German_language_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/communication/Mobilfunkantennenanlage_Niwre_at_the_German_language_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Mobilfunkantennenanlage_Niwre_at_the_German_language_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Infinera Corp
Lower demand led to lower revenues and higher loss, in the fiscal period ending Dec 26 2020 company decreased loss to $-0.05 per share, while Sales fell by -8.07% to $353.53 millions, year on year.
In the previous quarter company realized Sales of $340.21 millions and bottom line of $-0.19 per share.
Infinera Corp reported net loss of $-206.72 millions and Sales of $1.36 billions for the fiscal year 2020.
Company has decreased loss per share to $-1.10 from $-2.16 in the previous fiscal year, while Sales increased by 4.37 % from $1.30 billions a year ago.
INFN stock quotes, charts, profile
Growth Rates, Profitability, PE
Big 5 Sporting Goods Corp
Company displayed pleasant results in the fiscal fourth quarter of 2020. Sales were at $290.58 millions higher by 19.05% year on year and decreased by -4.71% quarter on quarter, while earnings per share soared by 5495.58 % to $0.94, sequentially income faded by -28.42%.
In the fiscal year 2020, Big 5 Sporting Goods Corp reported Sales of $1.04 billions and net income of $55.94 millions.
Eps surged by 545 % to $2.58 per share from $0.40 in the previous fiscal year, while Sales increased by 4.49 % from $996.50 millions a year ago.
|
![bank_interior_By_John_Bradley_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/banks/bank_interior_By_John_Bradley_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "bank_interior_By_John_Bradley_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Plumas Bancorp
In the fourth quarter of 2020 Plumas Bancorp had Revenues of $12.27 millions and earnings per share of $0.82. Revenues were up by 13.04% year on year and eps grew by 10.88 %.
From the preceding quarter, income per share increased by 15.59 % from $0.71 per share and Revenues advanced by 12.63 % from $10.90 millions.
In the fiscal year 2020, Plumas Bancorp reported Revenues of $43.68 millions and net income of $14.48 millions.
Eps decreased by -6.73 % to $2.77 per share from $2.97 in the previous fiscal year, while Revenue decreased by -1.15 % from $44.19 millions a year ago.
|
|
Recently Reported Results |
|
Kallo Inc
In the fourth quarter of 2020 Kallo Inc increased losses of $-0.03 per share compared to $-0.00 a year ago and increased losses from $-0.01 per share from the previous quarter.
Kallo Inc reported operating loss of $-35.557435 millions, in the fourth quarter of 2020, a deterioration from the operating shortfall of $-1.728984 millions, realized in fourth quarter of 2019
Kallo Inc reported net loss of $-36.06 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.03 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
KALO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Ampio Pharmaceuticals inc
In the fourth quarter of 2020 Ampio Pharmaceuticals Inc loss increased of $-0.02 per share compared to $-0.01 a year ago and from $-0.02 per share from the previous quarter.
Ampio Pharmaceuticals Inc reported operating shortfall of $-3.911 millions, in the fourth quarter of 2020, an improvement from the operating shortfall of $-7.145966 millions, realized in fourth quarter of 2019
Ampio Pharmaceuticals Inc reported net loss of $-15.89 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.09 from $-0.14 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
AMPE stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Cowen inc
Cowen Inc delivered very strong results in the fiscal time frame ending Dec 31 2020, where Sales soared by 78.89% to $502.92 millions, while company's earnings per share soared by 2512.48 % to $3.00 per share, from the same quarter a year ago.
In contrast to the third quarter Sales improved by 29.71 % from $387.74 millions and eps more than doubled by 383.3 % from $0.62 per share.
In the fiscal year 2020, Cowen Inc reported Sales of $1.62 billions and net income of $207.06 millions.
Eps surged by 1145.61 % to $7.10 per share from $0.57 in the previous fiscal year, while Sales surged by 54.68 % from $1.05 billions a year ago.
COWN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Brown forman Corporation
Brown Forman Corporation reported declining eps on increasing revenue in the financial time frame ending Jan 31 2021, where Sales grew by 3.74% to $1.22 billions in comparison to $1.18 billions on a year-over-year basis, while earnings decreased by -6.25% to $0.45 per share, income per share was $0.48 in the same quarter a year ago.
In the previous quarter company realized Sales of $1.27 billions and bottom line of $0.50 per share.
BFA stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Annovis Bio Inc
For the fourth quarter of 2020 earnings season Annovis Bio Inc lost money at $-0.25 per share, compared to results of $-0.87 per share a year ago quarter, In the previous quarter company realized $-0.15 per share.
from $0.00 millions in preceding quarter, increased losses from $-0.15 per share.
Annovis Bio Inc reported net loss of $-5.46 millions and Sales of $-0.03 millions for the fiscal year 2020.
Company recorded loss per share of $-0.87 compared to $1.73 in the previous fiscal year, while by -100 % from $4.28 billions a year ago.
ANVS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Soleno Therapeutics Inc
In the fourth quarter of 2020 earnings season Soleno Therapeutics Inc decreased loss of $-0.04 per share compared to $-0.35 a year ago and improved from $-0.11 per share from the previous quarter.
Soleno Therapeutics Inc reported operating loss of $-7.957 millions, in the fourth quarter of 2020 earnings season, a deterioration from the operating shortfall of $-6.752 millions, realized in fourth quarter of 2019
Soleno Therapeutics Inc reported net loss of $-24.64 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.39 from $-0.90 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
SLNO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
Recently Reported Results |
Infinera Corp
Lower demand led to lower revenues and higher loss, in the financial fourth quarter of 2020 company decreased loss to $-0.05 per share, while Sales fell by -8.07% to $353.53 millions, year on year.
In the previous quarter company realized Sales of $340.21 millions and bottom line of $-0.19 per share.
Infinera Corp reported net loss of $-206.72 millions and Sales of $1.36 billions for the fiscal year 2020.
Company has decreased loss per share to $-1.10 from $-2.16 in the previous fiscal year, while Sales increased by 4.37 % from $1.30 billions a year ago.
INFN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Industrial production
The industrial production growth rate accelerated compare to the slow down in previous month, due to increase in growing output at utilities.
|
Bluelinx Holdings Inc
Due to strong revenue growth company turned into profitability, Sales grew by 25.07% to $848.82 millions, earnings per share were at $2.77, compared to $-0.75 in the same quarter a year ago.
Sequentially profit plummeted by -51.6% from $5.72 per share and Sales decreased by -2.55% from $871.06 millions.
Bluelinx Holdings Inc reported earnings of $80.88 millions and Sales of $3.10 billions for the fiscal year 2020.
Company reported earnings per share of $8.55 compared to $-1.89 in the previous fiscal year, while Sales improved by 17.44 % from $2.64 billions a year ago.
BXC stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![well_in_Tsaidam_By_John_Hill_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/oil/well_in_Tsaidam_By_John_Hill_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "well_in_Tsaidam_By_John_Hill_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Calumet Specialty Products Partners L p
Weak demand caused increase in losses for the financial period ending Dec 31 2020, company's deficit per share grew to $-0.51 from $-0.48 where Sales fell by -28.51% to $553.90 millions from $774.80 millions a year ago.
In contrast to the third quarter Sales decreased by -2.48% from $568.00 millions and improved from $-0.70 per share.
Calumet Specialty Products Partners L P reported net loss of $-149.00 millions and Sales of $2.27 billions for the fiscal year 2020.
Net loss per share has widen to $-1.86 from $-0.55 in previous fiscal year, while Sales Tumbled by -34.3 % from $3.45 billions a year ago.
CLMT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/services/8381791238_4cf7083ed0_b.jpg "8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Kallo Inc
In the fourth quarter of 2020 earnings season Kallo Inc increased losses of $-0.03 per share compared to $-0.00 a year ago and increased losses from $-0.01 per share from the previous quarter.
Kallo Inc reported operating loss of $-35.557435 millions, in the fourth quarter of 2020 earnings season, a deterioration from the operating shortfall of $-1.728984 millions, realized in fourth quarter of 2019
Kallo Inc reported net loss of $-36.06 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.03 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
KALO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Producer Price Index
|
![Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/shopping/Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Personal Income and Spending
|
![Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/auto/Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Auto Sales
|
|
Ampio Pharmaceuticals inc
In the fiscal time frame ending Dec 31 2020 Ampio Pharmaceuticals Inc loss increased of $-0.02 per share compared to $-0.01 a year ago and from $-0.02 per share from the previous quarter.
Ampio Pharmaceuticals Inc reported operating loss of $-3.911 millions, in the fiscal time frame ending Dec 31 2020, an improvement from the operating shortfall of $-7.145966 millions, realized in fourth quarter of 2019
Ampio Pharmaceuticals Inc reported net loss of $-15.89 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.09 from $-0.14 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
AMPE stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Cowen inc
Cowen Inc delivered very strong results in the fourth quarter of 2020 earnings season, where Sales soared by 78.89% to $502.92 millions, while company's earnings per share soared by 2512.48 % to $3.00 per share, from the same quarter a year ago.
In contrast to the third quarter Sales improved by 29.71 % from $387.74 millions and eps more than doubled by 383.3 % from $0.62 per share.
In the fiscal year 2020, Cowen Inc reported Sales of $1.62 billions and net income of $207.06 millions.
Eps surged by 1145.61 % to $7.10 per share from $0.57 in the previous fiscal year, while Sales surged by 54.68 % from $1.05 billions a year ago.
COWN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Brown forman Corporation
Brown Forman Corporation reported declining eps on increasing revenue in the financial period ending Jan 31 2021, where Sales grew by 3.74% to $1.22 billions in comparison to $1.18 billions on a year-over-year basis, while earnings decreased by -6.25% to $0.45 per share, income per share was $0.48 in the same quarter a year ago.
In the previous quarter company realized Sales of $1.27 billions and bottom line of $0.50 per share.
BFA stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Annovis Bio Inc
For the fourth quarter of 2020 Annovis Bio Inc lost money at $-0.25 per share, compared to results of $-0.87 per share a year ago quarter, In the previous quarter company realized $-0.15 per share.
from $0.00 millions in preceding quarter, increased losses from $-0.15 per share.
Annovis Bio Inc reported net loss of $-5.46 millions and Sales of $-0.03 millions for the fiscal year 2020.
Company recorded loss per share of $-0.87 compared to $1.73 in the previous fiscal year, while by -100 % from $4.28 billions a year ago.
ANVS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Soleno Therapeutics Inc
In the fourth quarter of 2020 earnings season Soleno Therapeutics Inc decreased loss of $-0.04 per share compared to $-0.35 a year ago and improved from $-0.11 per share from the previous quarter.
Soleno Therapeutics Inc reported operating deficit of $-7.957 millions, in the fourth quarter of 2020 earnings season, a deterioration from the operating loss of $-6.752 millions, realized in fourth quarter of 2019
Soleno Therapeutics Inc reported net loss of $-24.64 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.39 from $-0.90 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
SLNO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Optinose Inc
Company lost money at $-0.46 per share in the fiscal period ending Dec 31 2020, although its Sales surged by 47.52% to $16.35 millions from the same quarter a year ago.
In the previous quarter company realized Sales of $15.44 millions and $-0.43 per share.
Optinose Inc reported net loss of $-99.79 millions and Sales of $49.12 millions for the fiscal year 2020.
Company has decreased loss per share to $-2.07 from $-2.63 in the previous fiscal year, while Sales surged by 41.83 % from $34.63 millions a year ago.
OPTN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
Tweet
